TAY-SACHS
DISEASE
D O N E BY
S H A I L A R O B E R T H A M E L D O N
INTRODUCTION
Rare disorder passed from parents
to child
Absence of an enzyme that helps
break down fatty substances called
gangliosides
Build up to toxic levels in the child's
brain and affect the function of the
nerve cells.
MECHANISM
Tay-Sachs is an
AutosomalRecessive disease
caused by mutations in both
alleles of a gene (HEXA) on
chromosome 15 (15q24.1)
HEXA codes for the alpha
subunit of the enzyme beta
hexosaminidase A.
Normally, Beta -hexosaminidase A helps to degrade a
lipid called GM2 ganglioside
In Tay-Sachs individuals , the enzyme is absent or
present only in very reduced amounts , allowing
excessive accumulation of the GM2ganglioside in
neurons.
TYPES OF TAY- SACHS
Tay-Sachs disease is classified based on the time of
onset of neurological symptoms
Infantile TSD - Between 3 and 10 Month(Death
before the age of 4 or 5 Years)
Juvenile TSD (Between 2 and 10 Years)Extremely
rare (Die between 5-15 Years)
Adult/Late Onset TSD (Between 20 and 30Years)-
Usually Non Fatal
PATHOPHYSIOLOGY
DIAGNOSIS
Simple Blood Test: To measure
the body’s level of
hexosaminidase A (patients
withTay-Sachs lack most or all of
this protein whereas levels are
reduced in other forms of
Hexosaminidase A deficiency).
Genetic Testing (DNA): PND
and PGD
Eye Examination: Classic cherry-
red spot in the center of the
eye's macula (Retina part)
TREATMENT AND PREVENTION
TREATMENT GOAL
The goal of the Treatment is
Support and Comfort
MANAGEMENT WAYS
 Physical TherapyChest
PhysiotherapyFeeding Tubes,
 Wheelchairs,
 Canes andWalkers
 Medication (Anti-seizure)
PREVENTION
NO Cure for the Tay - Sach
Disease
Methods of Prevention:
 Antenatal diagnosis (AND)-
Amniocentesis andChorionic
Villus Sampling
 Preimplantation genetic
diagnosis (PGD)
 Mate selection
THANK
YOU

TAY-SACHS DISEASE Presentation

  • 1.
    TAY-SACHS DISEASE D O NE BY S H A I L A R O B E R T H A M E L D O N
  • 2.
    INTRODUCTION Rare disorder passedfrom parents to child Absence of an enzyme that helps break down fatty substances called gangliosides Build up to toxic levels in the child's brain and affect the function of the nerve cells.
  • 3.
    MECHANISM Tay-Sachs is an AutosomalRecessivedisease caused by mutations in both alleles of a gene (HEXA) on chromosome 15 (15q24.1) HEXA codes for the alpha subunit of the enzyme beta hexosaminidase A.
  • 4.
    Normally, Beta -hexosaminidaseA helps to degrade a lipid called GM2 ganglioside In Tay-Sachs individuals , the enzyme is absent or present only in very reduced amounts , allowing excessive accumulation of the GM2ganglioside in neurons.
  • 6.
    TYPES OF TAY-SACHS Tay-Sachs disease is classified based on the time of onset of neurological symptoms Infantile TSD - Between 3 and 10 Month(Death before the age of 4 or 5 Years) Juvenile TSD (Between 2 and 10 Years)Extremely rare (Die between 5-15 Years) Adult/Late Onset TSD (Between 20 and 30Years)- Usually Non Fatal
  • 7.
  • 8.
    DIAGNOSIS Simple Blood Test:To measure the body’s level of hexosaminidase A (patients withTay-Sachs lack most or all of this protein whereas levels are reduced in other forms of Hexosaminidase A deficiency). Genetic Testing (DNA): PND and PGD Eye Examination: Classic cherry- red spot in the center of the eye's macula (Retina part)
  • 9.
    TREATMENT AND PREVENTION TREATMENTGOAL The goal of the Treatment is Support and Comfort MANAGEMENT WAYS  Physical TherapyChest PhysiotherapyFeeding Tubes,  Wheelchairs,  Canes andWalkers  Medication (Anti-seizure) PREVENTION NO Cure for the Tay - Sach Disease Methods of Prevention:  Antenatal diagnosis (AND)- Amniocentesis andChorionic Villus Sampling  Preimplantation genetic diagnosis (PGD)  Mate selection
  • 10.